Short report: Short course combination therapy for giardiasis after nitroimidazole failure

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 1, 2010, Pages 171-173

  Lopez Velez, Rogelio ^a   Batlle, Carolina ^a,b   Jiménez, Carolina ^a   Navarro, Miriam ^a   Norman, Francesca ^a   Perez Molina, Jose ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IMMUNOGLOBULIN; MEPACRINE; METRONIDAZOLE; NITROIMIDAZOLE; PAROMOMYCIN; TINIDAZOLE; ANTIPARASITIC AGENT; NITAZOXANIDE; NITROIMIDAZOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GIARDIASIS; HUMAN; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT RESPONSE; ANIMAL; DRUG COMBINATION; METHODOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTIPARASITIC AGENTS; DRUG THERAPY, COMBINATION; GIARDIASIS; HUMANS; NITROIMIDAZOLES; THIAZOLES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77954607815     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0742     Document Type: Article

References (12)

1. Escobedo AA, Cimerman S, 2007. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother 8: 1885-1902.
2. Gardner TB, Hill DR, 2001. Treatment of giardiasis. Clin Microbiol Rev 14: 114-128.
3. Petri WA, 2005. Treatment of giardiasis. Curr Treat Options Gastroenterol 8: 13-17.
4. World Health Organization, 2007. Drugs for parasitic infections. Med Lett Drugs Ther 5 (Suppl): e1-15.
5. Zaat JO, Mank TG, Assendelft WJ, 1997. A systematic review on the treatment of giardiasis. Trop Med Int Health 2: 63-82.
6. Abboud P, Lemee V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L, 2001. Successful treatment of metronidazole and albendazole resistant giardiasis with nitazoxanide in a patient with acquired immunodefiency syndrome. Clin Infect Dis 32: 1792-1794. (Pubitemid 32532010)
7. Yereli K, Balcioglu IC, Ertan P, Limoncu E, Onag A, 2001. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. Clin Microbiol Infect 10: 527-529. (Pubitemid 38961577)
8. Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA, 2001. Treatment of patients with refractory giardiasis. Clin Infect Dis 33: 22-28.
9. Smith PD, Gillin FD, Spira WM, Nash TE, 1982. Chronic giardiasis: studies on drug sensitivity, toxin production and host immune response. Gastroenterology 83: 797-803.
10. Taylor GD, Wenman WM, Tyrell DL, 1987. Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis. CMAJ 136: 1179-1180.
11. Cacopardo B, Patamia I, Bonaccorso V, Di Paola O, Bonforte S, Brancati G, 1995. Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis. Clin Ter 146: 761-767.
12. Mørch K, Hanevik K, Robertson LJ, Strand EA, Langeland N, 2008. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 56: 268-273.